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The cis-acting elements for Brome mosaic virus (BMV) RNA synthesis have been characterized primarily for
RNA3. To identify additional replicase-binding elements, nested fragments of all three of the BMV RNAs, both
plus- and minus-sense fragments, were constructed and tested for binding enriched BMV replicase in a
template competition assay. Ten RNA fragments containing replicase-binding sites were identified; eight were
characterized further because they were more effective competitors. All eight mapped to noncoding regions of
BMV RNAs, and the positions of seven localized to sequences containing previously characterized core
promoter elements (C. C. Kao, Mol. Plant Pathol. 3:55-62, 2001), thus suggesting the identities of the
replicase-binding sites. Three contained the tRNA-like structures that direct minus-strand RNA synthesis,
three were within the 3 region of each minus-strand RNA that contained the core promoter for genomic
plus-strand initiation, and one was in the core subgenomic promoter. Single-nucleotide mutations known
previously to abolish RNA synthesis in vitro prevented replicase binding. When tested in the context of the
respective full-length RNAs, the same mutations abolished BMV RNA synthesis in transfected barley proto-
plasts. The eighth site was within the intercistronic region (ICR) of plus-strand RNA3. Further mapping
showed that a sequence of 22 consecutive adenylates was responsible for binding the replicase, with 16 being
the minimal required length. Deletion of the poly(A) sequence was previously shown to severely debilitate BMV
RNA replication in plants (E. Smirnyagina, Y. H. Hsu, N. Chua, and P. Ahlquist, Virology 198:427-436, 1994).
Interestingly, the B box motif in the ICR of RNA3, which has previously been determined to bind the 1a protein,
does not bind the replicase. These results identify the replicase-binding sites in all of the BMV RNAs and
suggest that the recognition of RNA3 is different from that of RNA1 and RNA2.
The replication of positive-strand RNA viruses is essential
for pathogenesis. The responsible enzyme, the viral replicase,
is a complex that includes the virus-encoded RNA-dependent
RNA polymerase, additional viral replicase proteins, and host
factors (6, 32). In addition, specific interactions between the
viral genomic RNAs and viral replicase are required for rep-
lication and/or transcription of the viral RNAs (1, 6). The
interaction process is likely to be quite complex because an
RNA virus expresses different classes of RNAs at programmed
levels and times.
Brome mosaic virus (BMV) belongs to the alphavirus-like
superfamily of plant and animal positive-strand RNA viruses.
The BMV genome is divided into three capped RNAs, desig-
nated RNA1, RNA2, and RNA3 (3, 26). RNA1 and RNA2
encode replication-associated proteins, while RNA3 encodes
two proteins required for systemic movement of the virus in
plants and encapsidation of viral RNAs. Due to the dicistronic
nature of RNA3, the second cistron encoding the capsid is
translated from subgenomic RNA that is transcribed from the
subgenomic promoter. In all, three classes of RNAs must be
produced during successful BMV replication: genomic minus-
strand, genomic plus-strand, and subgenomic RNAs.
cis-acting elements for efficient genomic plus-strand, minus-
strand, and subgenomic BMV RNA synthesis have been char-
acterized by a combination of approaches, including RNA syn-
thesis by the BMV replicase in vitro (37), transfection of BMV
RNAs into protoplasts (34), analysis in plants (7), and repli-
cation in Saccharomyces cerevisiae, which is permissive for
BMV replication and transcription (23). Each study generally
focused on one cis-acting element and on RNA3, which does
not contain functions directly required for replication. None-
theless, a number of required elements have been identified
(Fig. 1).
The 3 noncoding regions (NCR) of BMV genomic plus-
strand RNAs form a tRNA-like structure that directs the ini-
tiation of minus-strand RNA synthesis in vitro (10, 15) and in
vivo (38, 46). Stem-loop C (SLC) within the tRNA-like struc-
ture of RNA3 binds the BMV replicase through an RNA
structure called a clamped adenine motif (29). Given the highly
similar structures predicted for RNA1 and RNA2, it is likely
that the same structures are required to direct their minus-
strand replication (Fig. 1). A mutation in SLC in RNA2 was
shown to affect RNA replication in barley protoplasts (39).
A 26-nucleotide (nt) sequence at the 3 end of minus-strand
RNA2 was capable of directing genomic plus-strand RNA2
initiation (49). One feature of this sequence is a sequence
called the cB box. The cB box is also found in minus-strand
RNA1 and in the intercistronic region (ICR), but not at the 3
region, of minus-strand RNA3. The core of the cB box is a 4-nt
sequence, CCAA, which is conserved at comparable positions
in RNA1 and RNA2 of other members of the Bromoviridae
(48).
The cB box is the sequence complementary to a previously
identified regulatory element, called the B box (16, 25, 33, 35).
Of course, the B box is present at the position complementary
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to the locations of the cB boxes (Fig. 1). In barley cells, the
deletion of the B box resulted in defects in BMV replication
and transcription (35, 50). In yeasts the B box in RNA2 binds
the 1a protein in a process postulated to be required for trans-
locating RNA2 into membranes, presumably the location of
the BMV replicase and translation (11, 12).
The 200-nt ICR in RNA3 also contains a number of other
regulatory sequences in addition to the B box. The ICR con-
tains an enhancer that was involved in regulating RNA repli-
cation and transcription (Fig. 1) (51). It also contains a cis-
acting sequence required for the assembly of a functional
BMV replicase complex when BMV RNAs are expressed in
yeast (Fig. 1) (23, 37, 40, 52). The complement of the ICR
contains the promoter for subgenomic RNA4 transcription,
which consists of an upstream A/U-rich sequence, a poly(U)
tract, and the 20-nt core promoter sequence recognized by the
BMV replicase in vivo and in vitro (16, 17, 42, 45).
For this study, we sought to identify the replicase-binding
sites in all of the BMV RNAs. We expected to encounter
sequences known to direct BMV RNA synthesis and possibly
other regulatory sequences that have not been linked to rep-
licase binding. Eight such sequences were identified in vitro
and characterized.
MATERIALS AND METHODS
Molecular manipulations. DNAs that can direct the transcription of the de-
sired portion of the RNAs were generated by PCR using the Vent DNA poly-
merase (New England Biolabs); cDNA clones of BMV RNAs; pB1TP3, pB2TP5
and pB3TP8 as templates (24); and appropriate primers (DNA Genesys, Sigma
Inc.). The forward primer contained a T7 promoter with an initiation guanylate
that can direct plus-strand RNA transcription. The reverse primer contains an
SP6 promoter with an initiation guanylate that can direct the synthesis of minus-
strand RNAs (Fig. 2A). The DNA products for transcription were purified by
phenol-chloroform extraction and ethanol precipitation. For in vitro transcrip-
tion, we used the protocol described in the work of Kao et al. (27) and transcripts
were purified from denaturing gels after excision of bands of the correct size and
elution of crushed gel fragments with 0.3 M sodium acetate.
Mutations within BMV cDNAs were made by use of a site-directed mutagen-
esis kit (Stratagene, San Diego, Calif.) and appropriate DNA oligonucleotides.
The existence of each mutation and the absence of spurious changes were
confirmed by DNA sequencing using a Big Dye Terminator v3.1 cycle sequencing
kit (Applied Biosystems, Inc.)
Homopolyadenylates of various lengths were generated by alkaline hydrolysis
of high-molecular-weight poly(A) (Sigma Aldrich Inc., St. Louis, Mo.). Treat-
ment with 0.2 M NaOH at 37°C for 30 min generated a ladder of fragments that
were individually purified from a denaturing gel.
Construction of chimeric BMV RNAs. Chimeric BMV RNAs were made to
examine whether the replicase-binding motifs function together with other cis-
acting elements. Plasmids encoding chimeric BMV cDNAs were made by use of
a combination of PCR, site-directed mutagenesis, and swapping of restriction
fragments into the appropriate background according to the protocol of Higuchi
et al. (21). All of the cDNAs were confirmed to have only the intended changes
by DNA sequencing. The specifics for the construction of the plasmids are quite
involved. Details and maps will be provided upon request.
RNA replicase assay. BMV replicase was prepared from infected barley as
previously described (53). Standard replicase assays were carried out as de-
scribed by Adkins et al. (2). Template competition assays were performed with
a 2 nM concentration of20/13, which directs robust synthesis of a 13-nt product
and a 14-nt product. The latter results from nontemplated addition due to the
terminal transferase activity of the BMV replicase (42, 43). Increasing concen-
trations of each competitor RNA were tested, and the effects on the accumula-
tion of both products were quantified. All quantifications of radiolabel were
performed with a PhosphorImager and Molecular Dynamics software. Each
competition assay tested six RNA concentrations, and RNAs that were effective
competitors were tested at least three times to determine the standard error for
the concentration of the competitor required to reduce synthesis from the ref-
erence RNA to 50% (IC50).
BMV replication in barley protoplasts. Mutants and infectious transcripts
used for transfection of barley protoplasts were produced as previously described
(19). Protoplasts were isolated from 5-day-old primary barley leaves as described
by Kroner et al. (31) and were usually inoculated with 0.5 g each of capped
transcripts of the desired combination of the three BMV RNAs. Protoplasts were
harvested at specific times after transfection (usually 12 h) for total RNA ex-
traction. The RNA was analyzed by Northern blot hybridization that used probes
specific for the 3-terminal 200 nt of the minus- or plus-strand BMV RNA3 (31).
Images of rRNAs were photographed from the nylon membrane to which RNAs
were transferred. The RNAs were stained with ethidium bromide.
RESULTS
Mapping of replicase-binding sites. To identify sites in BMV
RNAs required in vitro for efficient replicase binding, a series
of cDNA fragments was synthesized by PCR. Each fragment
contained a T7 promoter on the sense strand and a SP6 pro-
moter on the antisense strand to allow the production of plus-
and minus-sense transcripts, respectively (Fig. 2A). Each RNA
fragment was ca. 200- or 400-nt long and overlapped its neigh-
boring fragments by 40 nt. The nesting of the RNA fragments
was designed to decrease the possibility of deleting an RNA
element required for replicase binding. For nomenclature,
each RNA fragment was named by using the BMV RNA from
which it was derived, a symbol indicating whether it was pos-
itive () or negative () sense, and a number indicating the
order of the DNA template in the nested set. For example,
B1()1 indicates that the fragment was derived from BMV
RNA1, was positive sense, and was the 5-most fragment in a
series of nested fragments. The nucleotide positions for each
FIG. 1. Summary of previously reported cis-acting sequences in
BMV RNAs. Locations of the cis-acting sequences are denoted by
shaded rectangles. Near each rectangle is a brief description of the
name of each motif and the nucleotide positions at which the motif
resides. Plus- and minus-strand RNAs are denoted with “” or “. ”
The first nucleotide at the 5 end of the plus- and minus-strand RNAs
are designated, respectively, with 1 and 1. The amount of area
shaded denotes the approximate location within the RNA and is not to
scale.
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RNA fragment are listed in Table 1. The positions of the
nucleotides are named from 5 to 3.
Each RNA fragment was used to compete with the BMV
replicase from at least one reference RNA that is normally
capable of directing specific RNA synthesis by the replicase
(42). A reference RNA named 20/13 that was used in all
template competition assays was the functional core promoter
template for subgenomic RNA synthesis. A second RNA that
could direct genomic minus-strand RNA, named SLC  8
(29), was used as an independent reference template for the
competition assays with RNAs derived from RNA3. However,
we found that the IC50s observed for 20/13 and SLC  8
showed no significant differences from one another, and we
stopped using SLC 8 for the assays of fragments from RNA1
and RNA2.
Three general classes of competitors were identified. First,
the majority had IC50s that did not reach 50% of all of the
concentrations tested. Based on the highest concentration of
competitor tested, these were assigned an IC50 of20 nM. The
vast majority of these RNAs were not expected to reach the
IC50 even if much higher competitor concentrations were
tested. A second class of competitor contained two RNA frag-
ments, B2()5 and B3()7, which had IC50s of 19.1 and 16.9
nM, respectively. These represent weak binders that are not
emphasized in this study. A third class of eight fragments had
IC50s of between 3 and 5 nM. We shall refer to these eight as
effective binders. Representative results from an effective
binder and a nonbinding RNA fragment are represented in
Fig. 2B.
The eight effective binders are located in both plus- and
minus-strand RNAs of the three BMV RNAs. Their locations
in BMV RNAs and IC50s are summarized in Fig. 2C. Two
effective binders were from plus-strand RNA3 and were lo-
cated, respectively, in the ICR [B3()8] and in the 3 tRNA-
like structure region [B3()13]. For minus-strand BMV
RNA3, B3()1, the 3-most fragment, and B3()8, which con-
tains the complement of the ICR, were effective replicase bind-
ers (Fig. 2C). Plus-strand RNA1 and RNA2 each had one
effective binder that mapped to their respective 3-terminal
fragments, B1()10 and B2()9. The respective 3-terminal
fragments of minus-strand RNA1 and RNA2, B1()1 and
B2()1, were also effective binders. Based on the previous
characterizations of the cis-acting sequences within BMV
RNAs presented in the introduction, we could predict the
majority of the motifs within each of the eight effective binders.
The predictions are listed in Fig. 2C.
Stem-loop C is a major binding site in plus-strand BMV
RNAs. Within the tRNA-like structure of each of the plus-
strand BMV RNAs, the clamped adenine motif (CAM) in SLC
is expected to be the replicase-binding site that directs minus-
strand initiation (10, 29). RNA fragments B1()10, B2()9,
and B3()13 contain the 3 tRNA-like sequences that was
previously characterized for RNA synthesis (15) and for rep-
licase binding (10). We hypothesize that mutations in the CAM
within these three fragments would affect replicase binding
(Fig. 3A). Changing the clamped adenine to a guanine within
RNA fragments B1()10, B2()9, and B3()13 increased the
IC50 for replicase binding to 20 nM (Fig. 3B), in support of
the hypothesis that the SLC in BMV RNAs is required for
replicase binding in these fragments. To examine whether dis-
ruption of replicase binding in vitro is correlated with an effect
on RNA replication in cells, the same mutations were built into
full-length BMV RNAs and the replication of the resultant
RNAs were tested in barley protoplasts in combination with
the other two wild-type RNAs. A combination wherein all
three RNAs contained the clamped adenine mutation was also
tested (Fig. 3C, lanes 3 to 4 and 9 to 10), as was a combination
of all three wild-type transcripts (Fig. 3C, lanes 1 to 2). Con-
sistent with in vitro binding results, mutations in the CAM
decreased minus-strand RNA accumulation in barley proto-
plasts (Fig. 3C), likely accounting for a concomitant decrease
in plus-strand RNA3 accumulation (Fig. 3C). A mutation in
FIG. 2. Regions in BMV RNAs that confer higher-affinity binding
to the BMV replicase in vitro. (A) Schema used to generate desired
competitor RNAs. Overlapping cDNA fragments flanked by T7 and
SP6 promoters were produced by PCR using appropriate primers and
BMV plasmids from the work of Janda and Ahlquist (23). (B) Results
from a typical template competition assay used to determine the IC50
for each competitor RNA. The gel image shows the effects of a com-
petitor, B3()8, that binds the replicase and of B3()6, which does
not. Template 20/13 at 2 nM served as the reference RNA in these
assays. The amount of product from 20/13 is quantified against each
concentration of competitor to derive the IC50. % Syn., percent syn-
thesized. (C) Summary of the 10 RNA fragments that we detected to
bind the BMV replicase, their IC50s, the location of the BMV that they
encode, and the motif that may bind the replicase. Eight of the binders
for which IC50s were lower than 5 nM are considered effective and are
characterized further in this work. The motifs within these eight were
predicted based on previous characterizations detailed in the introduc-
tion. The weak replicase-binding motif within B2()5 was not previ-
ously identified, and its relevance in BMV replication remains to be
determined.
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RNA1 or in all three RNAs reduced all RNA accumulation to
background levels (Fig. 3C, lanes 3 to 4 and 9 to 10), likely due
to RNA1 or its encoded product being required for the for-
mation of active replicase (40). In contrast, while a mutation in
RNA2 decreased replication of RNA2 to near background
levels, it still allowed a reduced level of RNA4 transcription,
suggesting that the amount of 2a protein translated from the
replication-defective RNA2 was sufficient for some level of
RNA synthesis.
Subgenomic core promoter confers binding to BMV repli-
case. B3()8 contains stretches that are A/U rich, homouridy-
lates, and the core promoter for subgenomic initiation. The
subgenomic core promoter of 20 nt with a short template was
sufficient for replicase-binding RNA synthesis in vitro (42).
Four key residues at positions 17, 14, 13, and 11 rela-
tive to the initiation site are required for these activities (Fig.
4A) (43, 45). Therefore, we hypothesize that the core promoter
within B3()8 is responsible for replicase binding. A nucleo-
tide substitution changing 14A to a U in the context of
B3()8 caused the IC50 of the resultant RNA to become 20
nM (Fig. 4B). The same mutation in the context of full-length
RNA3 abolished subgenomic RNA4 synthesis and reduced the
levels of the other BMV RNAs (Fig. 4C). This result is con-
sistent with those from our recent characterizations of the
BMV core promoter (45).
The cB box in minus-strand RNA1 and RNA2 is required for
efficient BMV replicase binding. The 3 ends of minus-strand
BMV RNAs contain the core promoter for genomic plus-
strand RNA synthesis (47). The minimal requirement for
RNA2 was found to be a cB box approximately 16 nt from1C
(19, 47, 49). The cB box inhibited RNA synthesis when fused to
the promoter template for minus-strand RNA synthesis, sug-
gesting that it may bind the BMV replicase (48). The key
feature of the cB box is the motif CCAA since mutations in this
sequence had the most-severe effects on RNA synthesis by the
BMV replicase in vitro (48). Notably, the cB box is present
near the end of minus-strand RNA1 and RNA2. A comparable
sequence is present in the complement of the ICR, not at the
3 end of the minus-strand RNA3.
We hypothesize that B1()1 and B2()1 bind to the repli-
case through the cB box. Changing the cB box from CCAA to
GCAA in B1()1 and B2()1 caused the IC50 to change from
4 to 20 nM (Fig. 5B), indicating that the cB box plays a
significant role in binding the BMV replicase. RNA1 and
RNA2 with the same nucleotide changes were unable to pro-
duce either minus- or plus-strand RNAs in transfected proto-
plasts. The effect on genomic plus-strand accumulation was
expected since the mutations affect the core promoter for
genomic plus-strand RNA initiation. However, the effect on
minus-strand initiation was unexpected, given that the cB
boxes would not have been made before minus-strand initia-
tion. It is possible that the concomitant change in the B box in
the plus-strand RNAs affected minus-strand synthesis.
Next, we examined the role of the cB and/or B box in the
ICR of RNA3. In the template competition assay, B3()7
(containing the wild-type B box) had an IC50 of 20 nM, while
B3()7 (containing the cB box) had an IC50 of 16.9 nM.
Changing this cB box from 3 CCAA 5 to 3 GCAA 5 in the
context of B3()7 decreased replicase binding to 20 nM
(Fig. 2C and data not shown), indicating that the cB box in the
ICR of RNA3 did bind the BMV replicase, albeit not with the
same effectiveness as the comparable sequences in minus-
strand RNA1 and RNA2. The same mutation (BB3m1) in the
context of BMV RNA3 causes minus- and plus-strand RNA3
TABLE 1. Summary of the competitor RNAs used in the template competition assays
RNA1 RNA2 RNA3
Competitor Sequence (nt) Competitor Sequence (nt) Competitor Sequence (nt)
B1()1 1 to 200 B2()1 1 to 200 B3()1 1 to 200
B1()2 160 to 560 B2()2 160 to 560 B3()2 160 to 360
B1()3 520 to 920 B2()3 520 to 920 B3()3 320 to 520
B1()4 880 to 1280 B2()4 880 to 1280 B3()4 480 to 680
B1()5 1240 to 1640 B2()5 1240 to 1640 B3()5 640 to 840
B1()6 1600 to 2000 B2()6 1600 to 2000 B3()6 800 to 1000
B1()7 1960 to 2360 B2()7 1960 to 2360 B3()7 960 to 1160
B1()8 2320 to 2720 B2()8 2320 to 2720 B3()8 1120 to 1320
B1()9 2680 to 3080 B2()9 2665 to 2865 B3()9 1280 to 1480
B1()10 3034 to 3234 B3()10 1440 to 1640
B3()11 1600 to 1800
B3()12 1760 to 1960
B3()13 1917 to 2117
B1()1 3034 to 3234 B2()1 2665 to 2865 B3()1 1917 to 2117
B1()2 2674 to 3074 B2()2 2305 to 2705 B3()2 1754 to 1954
B1()3 2314 to 2714 B2()3 1945 to 2345 B3()3 1594 to 1794
B1()4 1954 to 2354 B2()4 1585 to 1985 B3()4 1434 to 1634
B1()5 1594 to 1994 B2()5 1225 to 1625 B3()5 1274 to 1474
B1()6 1234 to 1634 B2()6 865 to 1265 B3()6 1114 to 1314
B1()7 874 to 1274 B2()7 505 to 905 B3()7 954 to 1154
B1()8 514 to 914 B2()8 145 to 545 B3()8 794 to 994
B1()9 154 to 554 B2()9 1 to 200 B3()9 634 to 834
B1()10 1 to 200 B3()10 477 to 677
B3()11 317 to 517
B3()12 157 to 357
B3()13 1 to 200
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levels to be approximately 40% of wild-type levels. Again, the
effect on RNA replication is less than that of comparable
sequences in RNA1 and RNA2 (Fig. 3C). We have confirmed
the ca. twofold effect of mutations in the intercistronic cB/B
box with five additional single-nucleotide substitutions, and the
mutations have at most a two- to threefold effect on the sta-
bility of RNA3 (data not shown). For the sake of focusing on
the eight effective binding sites, the ICR cB/B box will not be
addressed further in this work.
RNA B3()1 is an effective replicase binder despite the
absence of a recognizable cB box. There are two candidates for
a sequence comparable to the cB box. First, the sequence 3
UUAA 5 exists in a position similar to the position of the 3
CCAA 5 sequences in minus-strand RNA1 and RNA2. Sec-
ond, Sullivan and Ahlquist (51) proposed that the sequence
from nt 20 to 29 in plus-strand RNA3 forms a B box-like motif
(named the BBL motif). We first mutated the UUAA se-
quence to GUAA in a mutant RNA named SK1. The SK1
mutation decreased minus- or plus-strand RNA3 accumulation
minimally, to 68 and 65% of that of the wild type (Fig. 5D,
lanes 1 to 2). In the template competition, the SK1 mutation
was tested in both plus- and minus-strand RNAs in the context
of B3()1 and B3()1, respectively. B3()1 did not bind the
BMV replicase, and the SK1 mutation did not alter this result
(Fig. 5E). In the context of minus-strand RNA, B3()1 had an
IC50 of 3.2 nM and the SK1 mutation changed the IC50 to 20
nM but did not abolish binding. The UUAA sequence thus
appears to have some, but perhaps not a major, role in RNA3
replication. A mutation in the BBL motif was made, changing
the 3 GCAA 5 sequence to 3 ACAA 5 (Fig. 5A). This
mutation, named SK2, reduced RNA binding (IC50  20 nM)
(Fig. 5A and E) and RNA3 accumulation in barley protoplasts
to 20% of that of the wild type (Fig. 5D, lanes 5 to 6). The
effective binding site within B3()1 thus appears to involve the
complement to the BBL motif identified by Sullivan and Ahl-
quist (51), with some contribution of neighboring sequences.
Intercistronic poly(A) tract. Thus far, we have identified
seven of the eight effective replicase-binding sites. The eighth
maps within B3()8, which spans nt 1120 to 1280 in the ICR,
adjacent to the fragment containing the cB/B box. Possible
replicase interaction motifs within this sequence include a rep-
licase assembly site (37), a replication enhancer (17), and a
homopolyadenylate sequence (17, 50). Given a number of rea-
sonable candidates that can bind the replicase, we decided to
more systematically locate the responsible sequence with a
series of RNA fragments derived from B3()8 (Fig. 6A). In
template competition assays, the IC50s of RNAs containing
sequence from nt 1120 to 1210 were all 20 nM while those of
RNAs containing nt 1190 to 1240 were lower than 3.8 nM (Fig.
6A). The most prominent feature within this sequence is the
FIG. 3. Roles of SLC in replicase binding and BMV RNA accumulation in barley protoplasts. (A) Schematic representation of the BMV RNAs
and the locations of the eight effective replicase-binding sequences. The shaded regions containing SLC are flanked with numbers denoting the
nucleotide positions of the RNA fragment. The bars represent BMV RNAs, and the portion of SLC containing the clamped adenine (circled) is
shown in the box. The term “SLCm” designates an RNA with a mutation in the clamped adenine. (B) IC50s of a number of RNAs that were used
in a template competition assay. RNA 20/3 served as a positive control, and its replicase-binding properties were characterized by Sivakumaran
et al. (45). The other RNAs contain the 3 NCR of the three BMV RNAs (Table 1). SLCm indicates that the clamped adenine was changed to
a guanine. (C) Effects of SLC mutations in transfected barley protoplasts. The gel image shows the effect of SLC mutations on genomic
minus-strand and genomic plus-strand accumulation. The identities of the most relevant RNAs used in the transfections are shown above the
image. “All” indicates that the RNAs were from protoplasts transfected with all three BMV RNAs that had mutated SLCs. The gel image of the
18S rRNAs is intended to show an internal loading control. WT, wild type.
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homopolyadenylate. To further define the site in the segment
responsible for replicase binding, we made and tested RNAs
B3()8a, B3()8b, and B3()8c, which contain overlapping
sequences derived from nt 1190 to 1240. All three were effec-
tive binders, again with the homopolyadenylate being common
to the three RNAs (Fig. 6A).
To examine whether the poly(A) sequence is required and
sufficient to bind the BMV replicase, poly(A) molecules of
differing lengths were prepared by alkaline hydrolysis of
poly(A). Molecules of 22 to 16 adenylates had IC50s lower than
3.5 nM (Fig. 6C). However, A15 had an IC50 of 20 nM (Fig.
6C). These results indicate that at least 16 polyadenylates are
required for efficient replicase binding. A DNA version of A22
had an IC50 of 20 nM, indicating that the BMV replicase
specifically recognized the RNA version of the poly(A).
Additional intramolecular RNA interactions. The observa-
tion that there is only one replicase-binding site each in plus-
and minus-strand RNA1 and RNA2 does not indicate that
interactions between the ends of BMV RNAs are dispensable
for RNA replication. To determine whether these interactions
do contribute to BMV replication, we made a series of chi-
meric RNAs in which the 5 and 3 NCR of BMV RNAs were
precisely exchanged without the introduction of extraneous
nucleotide changes. The names of the chimeric RNAs are in
three parts that are separated by slashes. The first part denotes
the origin of the 5 NCR, the middle portion denotes the
protein-coding region, and the third part denotes the origin of
the 3 NCR. For example, R2/1/2 will have the 5 and 3 NCR
from RNA2, respectively, and the coding sequence for 1a.
When the heterologous 5 NCR was fused to RNA2, RNA1,
or RNA3, as in constructs R1/2/2, R2/3/3, and R2/1/1, the
chimeras were debilitated in minus-strand RNA replication
(Fig. 7, lanes 7 to 15). However, when both the 5 and 3 ends
came from RNA2, as in R2/1/2, wild-type levels of RNA rep-
lication were observed (Fig. 7, lanes 4 to 6). Parallel results
were observed for the plus-strand versions of all of these RNAs
(data not shown). These results indicate that compatible pair-
ing of the 5 and 3 NCR in RNA2 is required for efficient
replication, even though there is only one detectable replicase-
binding site in plus- and minus-strand RNA2. A similar chi-
mera where the 2a coding sequence fused to the 5 and 3NCR
of RNA1 named R1/2/1 did not yield a replication-competent
RNA (data not shown). This negative result suggests that there
may be sequences in addition to the RNA1 NCR that are
required to function together for RNA replication.
DISCUSSION
In this report, we used an in vitro replicase-binding assay to
identify replicase-binding sites in all plus- and minus-strand
BMV RNAs. This approach has the benefit of identifying a
potential function in BMV RNA without having to fulfill all of
the requirements for RNA-dependent RNA synthesis in vitro
or in vivo. The competition assay can distinguish three classes
of competitor RNAs (Fig. 2): apparent nonbinders, ineffective
binders with IC50s from 15 to 20 nM, and effective binders with
IC50s lower than 5 nM. The eight effective binding sites are
positioned in the NCR of both RNA strands and in the inter-
cistronic region of RNA3 (Fig. 2C and Table 1). Except within
the polyadenylate sequence, which we did not test, single-
nucleotide substitutions in the other seven sites decreased both
replicase-binding in vitro and BMV RNA accumulation in
transfected protoplasts. For the poly(A) sequence, Smirnya-
gina et al. (50) demonstrated that a deletion of the polyade-
nylate tract resulted in debilitated RNA replication. Progeny
viruses recovered from this input mutant were either revertants
or had second-site mutations. Therefore, all eight effective
binding sites identified in vitro have roles in the infected cell.
B box versus the cB box. The roles of the SLC and sub-
genomic core promoter have been characterized extensively in
vitro and in vivo, and their functions in directing RNA synthe-
sis appear to be more straightforward. However, the B box and
cB boxes represent a more complex situation. The B box was
shown to be involved in BMV RNA replication (16, 35, 36).
The intercistronic B box in RNA3 was reported to bind to the
1a protein and to form the membrane-associated structure
where the BMV replicase is located in yeast (40). The B box of
plus-strand RNA2 also binds 1a (11). Pogue and Hall (34) have
tried to distinguish whether the B box functions in plus- or
minus-strand RNA, and they determined that the most likely
effect is through the plus-strand RNA. However, it is often
difficult to distinguish intricately linked effects in the cell. We
demonstrate in this work that the cB box in minus-sense RNA
is more important for replicase binding than the B box. Previ-
ously, we showed that the cB box in minus-strand RNA is
FIG. 4. Effects of the subgenomic core promoter on replicase bind-
ing and BMV RNA accumulation in cells. (A) Schematic of plus- and
minus-strand BMV RNA3s, with the eight identified replicase-binding
sites (shaded) and the location of the subgenomic core promoter. The
secondary structure of the subgenomic core promoter sequences was
predicted by the MFOLD program (55) and validated by mutational
analysis performed as described in the work of Sivakumaran et al. (45).
The locations of the key residues in the core promoter are indicated by
their positions relative to the initiation cytidylate (1). The mutation
at position 14A (mutated to a U) is shown by the arrow. (B) Quan-
titative results from competition assays in which the amounts of prod-
ucts synthesized from a 2 nM concentration of 20/13 are plotted
against each concentration of B3()8 and B3()8-14A/U. The IC50s
of the two RNAs were from two independent assays that were highly
similar. (C) Effects of the 14U mutation that abolished replicase
binding on BMV RNA accumulation in barley protoplast. The iden-
tities of the most-relevant RNAs in the transfected mixture are indi-
cated above the gel image. 18S rRNA serves as an internal loading
control. WT, wild type.
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required for the initiation of genomic plus-strand RNA syn-
thesis in vitro (47, 48). Taken together, both the B and cB
boxes appear to have independent and required roles in BMV
RNA replication. More specifically, the B box binds 1a and
regulates translation and replicase assembly while the cB box
binds the replicase for the initiation of genomic plus-strand
RNA synthesis. One prediction of this model is that a 1a
molecule(s) associated with the BMV replicase has a role dis-
tinct from that of free replicase-independent 1a molecules.
In yeast, mutations in the B box in the RNA3 ICR decreased
the half-life of the mutant RNA by more than 20-fold, while in
barley, we have found that RNAs with B box mutations reduce
RNA3 replication by only twofold, with about comparable
decreases in the RNA half-lives (data not shown). The results
with both yeast and barley show a role for the ICR B and/or cB
box in BMV infections, but there is a significant difference in
the magnitudes of the effects of mutations. While RNA decay
rates may differ significantly in yeast and barley, there may be
a trivial explanation for the observed differences: the muta-
tions examined in yeasts were deletions of multiple nucleo-
tides, while our results are from single-nucleotide substitu-
tions.
A different mode of BMV RNA3 recognition? Results from
our analysis confirmed the preexisting notion that the BMV
replicase recognized RNA1 and RNA2 by similar mechanisms
but that RNA3 was recognized in a different way. A demon-
stration of this difference was provided by effects of the muta-
tions in the cB/B boxes in the three BMV RNAs. Mutations in
RNA1 and RNA2 had more-severe effects on replicase binding
and on RNA replication than did mutations in the intercis-
FIG. 5. Role of the cB box on replicase binding and on BMV RNA accumulation in barley protoplasts. (A) Schematic of the RNAs examined
in this set of experiments. The shaded regions denote the positions of the eight replicase-binding sites. The three sites that were analyzed in this
set of experiments have numbers that denote the nucleotide positions flanking the fragments. The intercistronic B site, denoted with an asterisk,
is also examined in this figure. The RNA secondary structures are the predicted structures that contain a cB box in minus-strand RNA1 and RNA2
or the AAUU-box in RNA3 (47). Arrows identify single-nucleotide changes in the cB box motif in RNA1 and RNA2 and in the cB-like sequence
of RNA3. For RNA1 and RNA2, the mutations are simply named cB/B box mutations. In minus-strand RNA3, two mutations were made, and
the name of each is given in parentheses. Locations of the cB box and B box in the RNA3 ICR are denoted by asterisks. (B) Results from template
competition assays. RNA fragments with mutations are denoted by an addition to the names of the RNA. (C) Northern blot analysis of mutated
RNA accumulated in barley protoplasts. The most-relevant RNA in the transfected mixture is noted above the gel image. The identities of
wild-type (WT) and mutant RNAs are shown to the side of the image. (D) Effects of mutations in the 3 end of BMV RNA3 on RNA accumulation
in barley protoplasts. (E) Results from competition assay using B3()1 or B3()1 with the SK1 or SK2 mutation. The reference template is
20/13. The results were tested twice, yielding consistent results. % Syn., percent synthesis.
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tronic cB box in RNA3 (Fig. 5). Another striking difference
between RNA1 and RNA2 was the presence of only one ef-
fective binding site apiece in plus- and minus-strand RNA1
and RNA2 (near the initiation site for RNA synthesis), while
both plus- and minus-strand RNA3 had two effective binding
sites. It is likely that RNA3 requires additional sequences for
specific recognition by the BMV replicase since it is recognized
by the replicase in trans. Characterizations of viral cis-acting
elements, including those in BMV, have generally focused on
RNAs whose replication was not coupled to the production of
the replicase components. Such an analysis may miss some
requirements that are unique to the RNA(s) whose replication
is linked to the production of replication proteins.
The identification of only one effective binding site in each
plus- and minus-strand RNA1 and RNA2 does not mean that
additional interactions, such as ones that involve the 5-end–
3-end interactions or intermolecular interactions, are unim-
portant for BMV replication. Such interactions have been
demonstrated for a number of systems to provide the means to
fine tune the regulation of viral replication or transcription
against the needs of other required processes, such as transla-
tion (14, 18, 20, 22, 28, 30, 44). For BMV, the 5 portion of
RNA3 was shown to help the initiation of minus-strand RNAs
at the 3 end of the BMV RNA (9). Furthermore, we have
found that compatible 5 and 3 NCR of BMV RNA2 were
able to drive higher levels of a chimeric RNA, R2/1/2 (Fig. 7),
suggesting that additional interactions will prove important for
regulating BMV RNA levels. Our mapping results do suggest,
however, that not all of the participating sequences that inter-
act will necessarily bind the replicase.
The replicase for phage Q is the only other viral genome
analyzed systematically for replicase-binding sites. Q is a
monopartite RNA virus (54). Binding to the plus- and minus-
strand Q RNAs was mapped by electron microscopy and by
using an RNase protection assay and hybridization of the pro-
tected fragments to restriction fragments of the Q genome
(4). Interaction with the plus-strand involved two internal sites
(M and S) (reference 4 and references therein). However,
FIG. 6. The poly(A) sequence in the ICR can bind the BMV replicase. (A) Mapped sequences in B3()8 that contained at least one
replicase-binding sequence. The IC50s of RNAs tested in template competition assays are summarized to the right of the bars that denote the
portion of the RNA derived from B3()8. The initial mapping led to the identification of the sequence between nt 1190 and 1240 as the one
encoding a replicase-binding sequence. RNAs B3()8a, B3()8b, and B3()8c were made to further address the responsible sequence. In the
sequences shown, lowercase g’s represents nucleotides that were added to the BMV sequence (in uppercase letters) to allow transcription by the
T7 RNA polymerase. (B) Preparation of poly(A) molecules of various lengths for use in template competition assays. The gel contains the purified
RNAs separated in a 20% denaturing polyacrylamide gel and stained with toluidine blue. The nucleotide lengths of several marker RNAs are
shown to the left side of the gel. (C) Summary of the results from template competition assays for poly(A) molecules of different lengths or a
chemically synthesized molecule of 22 deoxyadenylates. The two gel images are from template competition assays performed with competitors of
22 or 15 adenylates. % Syn., percent synthesis.
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binding to the 3 end was detected only in the presence of the
host factor after the Q RdRp initiated RNA synthesis. Bind-
ing to the minus strand was primarily at the 3 end and oc-
curred with apparently lower affinity. In comparison, the BMV
replicase binds to the 3 regions of all plus- and minus-strand
RNAs; internal binding occurred only with RNA3.
Poly(A) tract. The intercistronic poly(A) tract has previously
been demonstrated to be required for BMV RNA replication
(17). We have found that the intercistronic poly(A) sequence
binds the BMV replicase specifically (Fig. 6). The BMV rep-
licase was shown to not bind to homocytidylates (2). At
present, we can only speculate about the component in the
replicase that binds poly(A). An obvious candidate is the cel-
lular poly(A)-binding protein, which requires a stretch of 12
adenylates for stable binding. We have found that 16 nt of the
typically 22-nt-long BMV poly(A) tract was sufficient to effec-
tively bind the BMV replicase. Another candidate is the eu-
karyotic homologue of the Q host factor, which also binds
poly(A) with high affinity (8, 41).
Viral poly(A) tracts are usually found, like cellular mRNAs,
at the 3 ends of viral RNAs. In other viral systems, the poly(A)
tail may regulate RNA replication and the timing of replication
and translation (5, 13, 20). It will be interesting to determine
further how an intercistronic poly(A) tract regulates processes
needed for BMV infection.
In summary, our analysis of the replicase-binding sites has
confirmed the role of many of the motifs that were previously
found to participate in BMV RNA replication and helps to
clarify the functions of these sequences. Results from this anal-
ysis will be useful for a more integrated view of the require-
ments for BMV replication and transcription.
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